SCHEMBL18801468

SCHEMBL18801468

COC(=O)c1c(C[S+]([O-])c2ccccc2Cl)ccc(Br)c1OC

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.37
MAPT P10636 3/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
KMT2A Q03164 3/20 0.35
PKM P14618 1/20 0.35
MEP1B Q16820 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
TOP1 P11387 1/20 0.33
HPGD P15428 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18801177 0.91 MEN1 (0.36) LMNAMAPTSMN1; SMN2GAATSHR
SCHEMBL18801182 0.89 MEN1 (0.39) LMNAMAPTSMN1; SMN2GAATSHR
SCHEMBL18801127 0.85 MEN1 (0.36) LMNAMAPTSMN1; SMN2GAATSHR
SCHEMBL18801069 0.83 KDM4E (0.32) LMNAGAAHPGD
SCHEMBL18801352 0.80 NPSR1 (0.35) LMNAMAPTSMN1; SMN2GAAKMT2A
SCHEMBL18801337 0.80 SMN1; SMN2 (0.37) LMNAPOLBSMN1; SMN2GAATSHR
SCHEMBL18801456 0.79 METAP2 (0.40) LMNAMAPTSMN1; SMN2GAATSHR
SCHEMBL18801342 0.77 ALDH1A1 (0.36) LMNAMAPTPOLBSMN1; SMN2NPC1
SCHEMBL1648309 0.76 LMNA (0.40) LMNAMAPTSMN1; SMN2GAATSHR
SCHEMBL6844882 0.75 LMNA (0.37) LMNAMAPTSMN1; SMN2GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 EP disclosed